OKY-1581, a new thromboxane synthetase inhibitor, was studied in a conscious canine model of coronary thrombosis. After thoracotomy with placement of a left circumflex coronary artery flow probe and implantation of an electrode into the circumflex artery, animals were assigned randomly to the following groups: 0.9% NaCI vehicle control or OKY-1581 1 mg/kg every 4 h intravenously for 24 h. During the drug treatment period, a 50 txA anodal current was passed through the circumflex electrode, and venous blood was obtained for platelet aggregation studies. As compared to control animals, the OKY-1581 treated animals developed a greater mean coronary flow at the end of the treatment period, smaller thrombi by wet weight, smaller infarcts, and fewer ventricular arrhythmias. Ex vivo platelet aggregation studies revealed significant inhibition of aggregation to standard aggregating agents for the drug treated group only. OKY-1581 is an effective antitbrombotic agent which maintains coronary flow after a thrombogenic stimulus, presumably via blockade of the synthesis of thromboxane by blood platelets.
!. Introduction hibition of thromboxane production may result in the utilization of platelet cyclic endoperoxides by Recent antithrombotic strategies have erathe vascular endothelium with an increase in prosphasized inhibition of selected platelet functions tacyclin production (Marcus et al., 1980) . including aggregation, adhesion and production of Several drugs have been reported as inhibitors vasoactive metabolites of the arachidonic acid of thromboxane synthetase, principally imidazole pathway, e.g. thromboxane A 2 (Moncada and and its derivatives (Moncada et al., 1977; Tai and Vane, 1979; Packham and Mustard, 1980 ). An Yuan, 1978) . One of the imidazoles, dazoxiben, appealing approach is thromboxane synthetase inhas been studied extensively in the laboratory and hibition with a resultant decrease in thromboxane in man and has shown promise in conditions generation by blood platelets and circulating ranging from angina pectoris to endotoxemia leukocytes, thereby leaving the endothelial pros- (Anonymous, 1983) . Preliminary studies with tacyclin production presumably intact. Indeed, in-OKY- 1581 (sodium (E)-3-[4-(3-pyridylmethyl) phenyl]-2-methylacrylate) and its hydrochloride salt, OKY-1555, have indicated that they are potent and selective inhibitors of thromboxane synthetase in experimental systems involving PGH 2 and in-* To whom all correspondence should be addressed: Depart- rophages (Miyamoto et al.. 1980 (Romson et al., 1980) . we hypothesized that the antiplatelet effect of OKY-1581 might limit Twenty-four h after the completion of surgery. coronary thrombosis thereby lessening the subscthe animal's heart rate, blood pressure, electroquent adverse events of myocardial infarction and cardiogram, and coronary blood flow were moniarrhythmia generation, tored. Animals were studied further only if: (1) they were free of electrocardiographic evidence of myocardial injury and/or necrosis, (2) they had no 2. Materials and methods evidence of significant arrhythmias (fewer than 5 premature ventricular complexes per min), (3) they had a normal phasic pattern of coronary blood 2.1. Surgical procedure flow. The animals were returned to their respective kennels and the study protocol was initiated on Male mongrel dogs, 15-20 kg, were anesthetized the second postoperative day if the above stated with intravenous sodium pentobarbital (30 mg/kg) criteria were satisfied. and artificially ventilated. A lead II electrocardio-
The experimental protocol, briefly outlined, was gram (ECG) was monitored throughout surgery, as follows. Day 1: surgery: day 2: recovery; day 3: Using aseptic technique, cannulae were placed in venous blood for platelet aggregation, treatment the left common carotid artery and jugular vein with drug or vehicle control every 4 h for 24 h, and exteriorized through the nape of the neck.
electrical stimulation of the LCX for 24 h with After a left thoracotomy, the heart was suspended concomitant ECG monitoring, venous blood for in a pericardiai cradle and the proximal left cirplatelet aggregation after the second dose of drug cumflex coronary artery (LCX) was isolated from (during electrical stimulation of the LCX), day 4: the surrounding tissues. A 28 gauge Teflon-coated venous blood for platelet aggregation; sacrifice. silver wire with 5 mm of the tip of a 25 gauge Animals were given 0.9% NaCI or OKY-1581 hypodermic needle secured on the wire's leading according to a random numbers table. OKY-1581, end was inserted into the LCX and affixed to the 1 mg/kg, (Ono Pharmaceutical Co., Osaka, Japan) heart with two superficial 3-0 silk epicardial suwas administered to the animals every 4 h intures. A pre-calibrated electromagnetic flow probe travenously for the next 24 h. (Carolina Instrument Co.) was placed on the LCX After the initial dose of drug or 0.9% Na('l. 2-3 mm proximal to the silver wire insertion and anodal current from a 9V battery was delivered to affixed to the epicardial surface of the heart with the intimal surface of the LCX via the Teflon-2-0 silk suture. The zero flow baseline was estabcoated wire. The current output of 50 p.A was lishcd by transient total occlusion of the LCX adjusted through a 250000 ~' 1 potentiometer placed followed by release. Coronary blood flow was in series. The ECG electrode leads were connected measured with a square-wave electromagnetic flow to a telemetry transmitter. The potentiometer with meter (Carolina Medical Electronics, Inc.). The the battery supply and ECG transmitter were kept pericardium and chest were closed in layers. Grass in a nylon jacket which allowed the dog unredisc electrodes were tunneled subcutaneously near stricted movement. the right foreleg and left hindleg and exteriorized Electrocardiographic data were received via realong with the intracoronary wire and flow probe lemetry and in turn were recorded on a tape through the thoracotomy incision. The dogs were recorder programmed to record 28 s of tracing given a single intramuscular injection of ampicillin cvery 15 min. The tape was played back later (3 mg/kg). Cannulae were flushed with 0.9% NaCI through a Grass model 7 oscillographic recorder and a dilute porcine heparin solution (50 units in for analysis of arrhythmias, 0.3 ml) (Sigma) was placed in the cannulae to
The 50 tzA current to the LCX was continued maintain patency, for 24 h (while drug dosing was continuing).
Venous blood for platelet studies was obtained fraction. Platelet rich plasma was diluted with after the second drug administration interval durplatelet poor plasma to a platelet count of ing the period of electrical stimulation and again 200000/mm s before use in the aggregation assays. at the end of the electrical stimulation at 24 h. The All platelet samples were assayed within 2 h of the animals were monitored for 30 rain for heart rate, time of blood collection. Aggregation was initiated blood pressure, electrocardiogram and coronary under 3 different conditions using a 50 ~1 aliquot blood flow by direct recording on a Grass model 7 of aggregating agent added to 450 ~1 of diluted oscillographic recorder. The animals then were platelet rich plasma. Aggregating stimuli included: anesthetized with 30 mg/kg of sodium pentobarcollagen (1:80 dilution of Ethicon Collagen Disbital and the heart was exposed as described above, persion -TDI50); 5.0 ttg ADP (Sigma); and Ventricular fibrillation was induced by a DC curarachidonic acid (Sigma) 0.65 mM with an addirent and the heart was removed. The LCX in the tional 10 ~tl of L-epinephrine (Sigma), 0.55 ttM in area of the wire insertion was dissected free and saline at pH 3. the artery was opened lengthwise. The wet Thromboxane measurements were not made in thrombus was removed intact from the intima and this study. weighed. The heart then was "'breadloafed" from apex to base into 7 mm thick transverse slices and 2.4. Statistical methods" incubated in 2,3,5-triphenyltetrazolium chloride (TTC) (Sigma) for 30 min at 37°C. TTC stains All data are expressed as the mean + standard normal tissues brick red due to the formazan dye error of the mean. The Student's t-test for unresulting from the reduction of TTC by the dehypaired observations was used to evaluate the statisdrogenases of viable myocardium. The irreversibly tical significance of the hemodynamic and infarct injured areas do not react with TTC and appear as data (Remington and Schork, 1970) . The Mannpale gray regions which are distinguished easily for Whitney test was used to evaluate the statistical purposes of quantification. Both the nonstained significance of the arrhythmia and platelet aggreand stained areas were removed and weighed to gation data (Conover, 1980) . A P value of < 0.05, permit calculation of infarct mass which is cxtreated vs. control, was considered to be statistipressed as a percent of the total left ventricle by tally significant. weight.
Sham operated controls with placement of the wire electrode and additional instrumentation were 3. Results not used for this study. Previous work (Romson et al., 1980 , and unpublished observations) suggests OKY-1581 had no significant effect on heart that sham operated animals do not spontaneously rate, blood pressure, the electrocardiogram, or develop occlusive thrombi, myocardial infarction coronary blood flow when administered acutely. or arrhythmias as a result of the instrumentation.
At the end of the 24 h period of drug administration and electrical stimulation, the mean arterial 2.3. Platelet aggregation studies blood pressures for both drug and control groups had decreased. Before OKY-1581 administration Platelet aggregation studies were performed the mean arterial pressure was 111_ 6 mmHg, using previously described spectrophotometric whereas at the end of the experiment blood presmethods (Romson et al., 1980) utilizing a Bio/Data sure was 93 + 10 mmHg. Observations were complatelet aggregometer. Platelet rich plasma was plete for only five of the seven animals studied. prepared by collecting foreleg venous blood in 1.0
For the control group the baseline blood pressure ml of 3.8% sodium citrate to a total volume of 10 was 109 + 5 mmttg, whereas at the completion of nal. This was centrifuged at 310 × g for 3 min to the study the blood pressure was 104 + 3 mmHg obtain the platelet rich plasma fraction and then (n = 11). at 2200 × g for 10 min to obtain the platelet poor There was no difference in the baseline mean coronary blood flows for the 0.9% NaCI treated or TABLE 2 drug treated animals: 20.4 + 1.3 ml/min vs. 22.1
Frequency of ventricular arrhythmias during the 24 h of electri-+ 1.1 ml/min, respectively. At the end of the cal stimulation of the circumflex artery experimental period, mean coronary flow was sigPv(',/IIR (%)" nificantly greater in the OKY-1581 treated group ('ontrol OKY-1581 than the control group: 11.1 + 4 ml/min vs. 2 + 1.6
In -11) (n = 7) ml/min, respectively (P < 0.05, treated vs. control).
0-6h 4.6± 2.8h 1.7± 1.7
In the control group nine of eleven animals had an 7-12 h 29.3 + 9.6 11.4 + 7.7 absence of LCX coronary blood flow at the end of 13-18 h 78.8 _+ 10.8 ~ 23.1 ± 15.5 ,t the study period. Of the remaining two animals, 19-24 tl 98.1 + 1.4" 27.3_+ 17.6 ' one had a modest reduction in LCX coronary flow " Premature ventricular contractions expressed as a percentage (24 tO 18 ml/min), whereas the other had a marked of the heart rate. h Mean + S.E.M. " n = 10. ,i p < 0.05 treated reduction (26 to 4 ml/min). In the drug treated vs. control. group, LCX coronary flow was absent in three of seven animals at the end of the experimental other drug and contrtol animals, there was no period, whereas the remaining four animals had direct relationship between thrombus size and inessentially no change in coronary flow from the farct size. beginning to the end of the experimental period Drug treated animals had fewer ventricular (22 vs. 19.5 ml/min), arrhythmias over the last 12 h of the study period The size of the thrombi in the drug treated than the control groups (table 2) . This difference group was one-fourth of that in the 0.9% NaC1 may, in part, be related to the time course of vehicle control group (table 1) . There was no apthrombus formation. In this experimental model, parent relationship between thrombus size and the coronary thrombosis most frequently occurs durcoronary blood flow: comparatively small thrombi ing the 4th to llth h of electrical stimulation were occasionally noted to be associated with an (unpublished observations) with the subsequent absence of coronary blood flow, however, large progressivc development of electrocardiographic thrombi were always occlusive, changes and disturbances in cardiac rhythm. Major Left ventricular infarction was considerably differences in the control and treated groups might smaller in the drug treated group as compared to not be expected until the last 12 h of stud),. the control group (table l). This observation also applied when infarct mass was expressed as a percentage of the left ventricle to correct for dif-I00 ferences in heart weights. Drug treated animals with nonocclusive thrombi and maintenance of Z 80 ~ ~ ~0 coronary flow had the smallest infarctions. For the were usually occlusive. We assume the reduction in coronary flow in this model to represent transient total occlusion of One animal in the control group died suddenly the circumflex artery due to intraluminal thrombi in the 1 l th h of electrical stimulation with ventricwhich embolize spontaneously (Folts et al., 1982) . ular fibrillation as the terminal arrhythmia. In the At some point, total occlusion may occur when a drug treated group, five of seven animals were "critical closing pressure" is reached due to arrhythmia-free including three animals with small thrombus causing a stenosis greater than 90% of areas of irreversibly injured myocardium as dethe circumflex diameter with or without superventermined by histochemical staining with triphenyling coronary vasomotor activity (Elzinga and tetrazolium. In the control animals, the ventricular Skinner, 1975; Burton, 1965; Uchida et al., 1975 ; arrhythmias typically were extended runs of Santamore et al., 1980) . A recent study by Sellers ventricular tachycardia, occasionally multiform. In and Ku (1982) has demonstrated the ability of the drug treated group, the arrhythmias were thrombin to promote coronary artery vasoconstricqualitatively similar, tion only after endothelial damage had been pro-OKY-1581 inhibited platelet aggregation in reduced. A similar mechanism might be operative in sponse to standard aggregation conditions ( fig. 1) . the present study. Thus, the induction of endoIn comparing the 4 h and 24 h aggregations to the thelial injury by an electrical current and the subpre-drug baseline (0 h), significant inhibition of sequent development of platelet adhesion and aggregation was evident at each point for ADP thrombosis would bring about formation of and arachidonic acid. For the collagen aggregatory thrombin which could then cause coronary artery condition, a significant difference was evident only vasospasm which would convert a partially obat 24 h. structing platelet thrombus to a totally occlusive For the control animal, no significant difthrombus. This could account for our finding of a ferences were observed for any of the time points markedly decreased coronary artery flow despite for any of the aggregating conditions as compared the presence of a relatively small thrombus. Our to the baseline states ( fig. 2) . model does not differentiate whether the primary effect of OKY-1581 is due to antithrombotic or antispasmodic properties. However, the ability of 4. Discussion nitroglycerin injection to restore the coronary flow pattern during the phasic oscillations in coronary OKY-1581, a thromboxane synthetase inhibiflow would suggest that aggregation of platelets at tor, has no direct vascular effects as suggested by the site of injury can lead to coronary artery Manufacturers Association l.oundation. We acknowledge the The decrease in ventricular arrhythmias in drug excellent secretarial assistance of Dixie Thomas. treated animals with no evidence of infarction and maintenance of coronary flow was not a surprising result. However. even those drug-treated animals
